- ►ahajournals.org N Galie, M Beghetti, MA Gatzoulis, J Granton, … - Circulation, 2006 - Am Heart Assoc From the Istituto di Cardiologia, Università di Bologna, Bologna, Italy (NG);
Cardiology Unit, Hôpital des Enfants, Geneva, Switzerland (MB); Adult
Congenital Heart Centre, Royal Brompton Hospital, and the National Heart ... Cited by 131 - Related articles - All 6 versions
ME Brickner, LD Hillis, RA Lange - The New England journal of medicine, 2000 - cat.inist.fr Congenital heart disease in adults: Second of two parts. ME BRICKNER, LD
HILLIS, RA LANGE The New England journal of medicine 342 ... Cited by 118 - Related articles - BL Direct - All 5 versions
WS Avila, EG Rossi, JAF Ramires, M Grinberg … - Clinical cardiology, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 68 - Related articles - BL Direct - All 4 versions
- ►onlinejacc.org K Niwa, JK Perloff, S Kaplan, JS Child, PD … - Journal of the American College of Cardiology, 1999 - Elsevier Seventy-seven patients were studied. Group A comprised 47 patients with VSD,
aged 23 to 69 years (mean 39.5 ± 10.2), follow-up 5 to 18 years (mean 7.2 ±
4.9); group B, 14 patients with truncus arteriosus, aged 27 to 50 years ... Cited by 62 - Related articles - BL Direct - All 8 versions
- ►cardiovascres.org C Veyssier-Belot, P Cacoub - Cardiovascular research, 1999 - cardiovascres.org Theories concerning the detailed physiopathology of pulmonary hypertension have
focused on endothelial and smooth muscle cells' chemical factors production and
response to different mediators. The endothelium produces vasoconstrictor ... Cited by 62 - Related articles - All 8 versions
- ►ahajournals.org GP Diller, MA Gatzoulis - Circulation, 2007 - Am Heart Assoc Pulmonary arterial hypertension of variable degree is commonly associated with
adult congenital heart disease. Depending on size and location of the underlying
cardiac defect as well as on repair status, pulmonary arterial hypertension ... Cited by 59 - Related articles - All 6 versions
MA Gatzoulis, P Rogers, W Li, C Harries, D … - International journal of cardiology, 2005 - Elsevier All 10 study patients (42±4 years; eight female) tolerated bosentan well. No
major adverse events or significant liver enzyme elevations were observed. All
but one patient felt better; none felt worse. Four patients experienced ... Cited by 56 - Related articles - All 7 versions
JC Wanstall, TK Jeffery - Drugs, 1998 - ingentaconnect.com Abstract Pulmonary hypertension (mean pulmonary arterial pressure >20mm Hg at
rest or >30mm Hg during exercise) occurs (i) as primary pulmonary hypertension
(no known underlying cause), (ii) as persistent pulmonary hypertension of ... Cited by 54 - Related articles - BL Direct - All 6 versions
I Schulze-Neick, N Gilbert, R Ewert, C Witt, … - American Heart Journal, 2005 - Elsevier Endothelin receptor antagonism has been introduced as an effective oral therapy
of patients with idiopathic pulmonary arterial hypertension. In view of the
pathophysiologic and histologic similarities between idiopathic pulmonary ... Cited by 52 - Related articles - All 26 versions
JT Granton, M Rabinovitch - Cardiology clinics, 2002 - Elsevier Pulmonary Arterial Hypertension (PAH) is a recognized complication of congenital
cardiac defects that are characterized by chronic left-to-right shunting. Viktor
Eisenmenger initially described the clinical features of a patient with PAH ... Cited by 47 - Related articles - BL Direct - All 3 versions
